Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial.

ABSTRACT:

SUBMITTER: Wallis RS 

PROVIDER: S-EPMC8332197 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature